The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy

References

• United Nations. World Population Ageing 2019: highlights (ST/ESA/SER.A/430) 2019 [ cited 2020 Jun 29]. Available from: https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf.
   Google Scholar
• United Nations. Ageing [ cited 2020 Aug 10]. Available from: https://www.un.org/en/sections/issues-depth/ageing/.
   Google Scholar
• Makinodan T. Nature of the decline in antigen-induced humoral immunity with age. Mech Ageing Dev. 1980 Sep-Oct;14(1–2):165–172. PubMed PMID: 7010008.
   PubMed Web of Science ®Google Scholar
• Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012 Jan;67(1):71–79. PubMed PMID: 20729232.
   PubMed Web of Science ®Google Scholar
• Matanock A. Evidence to recommendations and GRADE for PCV13 use among immunocompetent adults ≥65 years old. Presented to the Advisory Committee on Immunization Practices, February 27-28, 2019 and June 26-27, 2019. [cited 2020 Oct 13]. Available from: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2019-02/Pneumococcal-5-Matanock-508.pdf.
   Google Scholar
• Hanquet G, Krizova P, Valentiner-Branth P, et al. Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. Thorax. 2019 May;74(5):473–482. PubMed PMID: 30355641; PubMed Central PMCID: PMC6484683.
   PubMed Web of Science ®Google Scholar
• Djennad A, Ramsay ME, Pebody R, et al. Effectiveness of 23-valent polysaccharide pneumococcal vaccine and changes in invasive pneumococcal disease incidence from 2000 to 2017 in those aged 65 and over in England and wales. EClinicalMedicine. 2018 Dec;6(6):42–50. PubMed PMID: 31193709; PubMed Central PMCID: PMC6537583.
   PubMedGoogle Scholar
• Lessa F, Spiller M. Effectiveness of PCV13 in adults hospitalized with pneumonia using centers for medicare & medicaid services data, 2014-2017. Presented to the Advisory Committee on Immunization Practices, February 27-28, 2019 and June 26-27, 2019. [ cited 2020 Oct 13]. Available from: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2019-02/Pneumococcal-3-Lessa-508.pdf/.
   Google Scholar
• Lessa FC, Spiller M, Wu X, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine in us adults hospitalized with pneumonia, 2014–2017. Open Forum Infect Dis. 2019 Oct; 6(Suppl 2):S956–S957. PubMed Central PMCID: PMC6809715.
   Google Scholar
• Kolditz M, Schmitt J, Pletz MW, et al. Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of all-cause pneumonia in adults aged ≥60 years: a population-based, retrospective cohort study. Clin Infect Dis. 2019 May 30;68(12):2117–2119. PubMed PMID: 30462172.
   PubMed Web of Science ®Google Scholar
• Gessner BD, Jiang Q, Van Werkhoven CH, et al. A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands. Vaccine. 2019 Sep 10;37(38):5777–5787. PubMed PMID: 29861177.
   PubMed Web of Science ®Google Scholar
• Pick H, Daniel P, Rodrigo C, et al. Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18. Thorax. 2020 Jan;75(1):38–49. PubMed PMID: 31594801.
   PubMed Web of Science ®Google Scholar
• Isturiz RE, Ramirez J, Self WH, et al. Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia. Vaccine. 2019 May 31;37(25):3352–3361. PubMed PMID: 31072732.
   PubMed Web of Science ®Google Scholar
• Van Der Linden M, Imohl M, Perniciaro S. Limited indirect effects of an infant pneumococcal vaccination program in an aging population. PLoS One. 2019;14(8):e0220453. PubMed PMID: 31369597; PubMed Central PMCID: PMC6675109.
   PubMed Web of Science ®Google Scholar
• McLaughlin JM, Swerdlow DL, Khan F, et al. Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States. Hum Vaccin Immunother. 2019;15(4):841–849. PubMed PMID: 30676236; PubMed Central PMCID: PMC6605819.
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Collins S, Djennad A, et al. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. Lancet Infect Dis. 2018 Apr;18(4):441–451. PubMed PMID: 29395999.
   PubMed Web of Science ®Google Scholar
• Forstner C, Kolditz M, Kesselmeier M, et al. Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia. Vaccine. 2020 Jan 29;38(5):1129–1136. PubMed PMID: 31761500.
   PubMed Web of Science ®Google Scholar
• Diao WQ, Shen N, Yu PX, et al. Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: a systematic review and meta-analysis of randomized trials. Vaccine. 2016 Mar 18;34(13):1496–1503. PubMed PMID: 26899376.
   PubMed Web of Science ®Google Scholar
• Moberley S, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013 Jan;31(1):CD000422. PubMed PMID: 23440780; PubMed Central PMCID: PMC7045867.
   Google Scholar
• Van Werkhoven CH, Huijts SM, Bolkenbaas M, et al. The Impact of age on the efficacy of 13-valent pneumococcal conjugate vaccine in elderly. Clin Infect Dis. 2015 Dec 15;61(12):1835–1838. PubMed PMID: 26265498.
   PubMed Web of Science ®Google Scholar
• McLaughlin JM, Jiang Q, Isturiz RE, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against hospitalization for community-acquired pneumonia in older us adults: a test-negative design. Clin Infect Dis. 2018 Oct 30;67(10):1498–1506. PubMed PMID: 29790925; PubMed Central PMCID: PMC6206101.
   PubMed Web of Science ®Google Scholar
• Schmoele-Thoma B, Center KJ, Webber C, et al. Relationship of age to immunogenicity of 13-valent pneumococcal conjugate vaccine (PCV13) from the very young to the elderly. Presented at 10th International Symposium on Pneumococci and Pneumococcal Diseases; 2016 Jun 26-30; Glasgow, Scotland.
   Google Scholar
• Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015 Mar 19;372(12):1114–1125. PubMed PMID: 25785969.
   PubMed Web of Science ®Google Scholar
• Lewis N, Hsiao A, Hansen J, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in older adults. Open Forum Infect Dis. 2019 Oct 23;6(Suppl 2):S953–4. PubMed Central PMCID: PMC6811316.
   Google Scholar
• Gessner BD, Jiang Q, Van Werkhoven CH, et al. A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands. Vaccine. 2019 Jul 9;37(30):4147–4154. PubMed PMID: 31155413.
   PubMed Web of Science ®Google Scholar
• McLaughlin JM, Jiang Q, Gessner BD, et al. Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: a systematic review and pooled analysis. Vaccine. 2019 Oct 8;37(43):6310–6316. PubMed PMID: 31522807.
   PubMed Web of Science ®Google Scholar
• Isturiz R, Sings HL, Hilton B, et al. Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert Rev Vaccines. 2017 Oct;16(10):1007–1027. PubMed PMID: 28783380.
   PubMed Web of Science ®Google Scholar
• Ahmed SS, Pondo T, Xing W, et al. Early Impact of 13-valent pneumococcal conjugate vaccine use on invasive pneumococcal disease among adults with and without underlying medical conditions-united states. Clin Infect Dis. 2020 Jun 10;70(12):2484–2492. PubMed PMID: 31402387.
   PubMed Web of Science ®Google Scholar
• Shea KM, Edelsberg J, Weycker D, et al. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis. 2014 Mar;1(1):ofu024. PubMed PMID: 25734097; PubMed Central PMCID: PMC4324183.
   PubMedGoogle Scholar
• Pelton SI, Bornheimer R, Doroff R, et al. Decline in pneumococcal disease attenuated in older adults and those with comorbidities following universal childhood PCV13 Immunization. Clin Infect Dis. 2019 May 17;68(11):1831–1838. PubMed PMID: 30239637; PubMed Central PMCID: PMC6522679.
   PubMed Web of Science ®Google Scholar
• Pelton SI, Shea KM, Farkouh RA, et al. Rates of pneumonia among children and adults with chronic medical conditions in Germany. BMC Infect Dis. 2015 Oct 30;15(1):470. PubMed PMID: 26515134; PubMed Central PMCID: PMC4627378.
   PubMed Web of Science ®Google Scholar
• Van Hoek AJ, Andrews N, Waight PA, et al. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect. 2012 Jul;65(1):17–24. PubMed PMID: 22394683.
   PubMed Web of Science ®Google Scholar
• Sheikh S, Biundo E, Courcier S, et al. A report on the status of vaccination in Europe. Vaccine. 2018 Aug 9;36(33):4979–4992. PubMed PMID: 30037416.
   PubMed Web of Science ®Google Scholar
• Torres A, Cilloniz C, Blasi F, et al. Burden of pneumococcal community-acquired pneumonia in adults across Europe: a literature review. Respir Med. 2018 Apr;137:6–13. PubMed PMID: 29605214.
   PubMed Web of Science ®Google Scholar
• Ramirez JA, Wiemken TL, Peyrani P, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–1812. PubMed PMID: 29020164.
   PubMed Web of Science ®Google Scholar
• Morimoto K, Suzuki M, Ishifuji T, et al. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS One. 2015;10(3):e0122247. PubMed PMID: 25822890; PubMed Central PMCID: PMC4378946.
   PubMed Web of Science ®Google Scholar
• Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. Adults. N Engl J Med. 2015 Jul 30;373(5):415–427. PubMed PMID: 26172429; PubMed Central PMCID: PMC4728150.
   PubMed Web of Science ®Google Scholar
• Ramirez J, Furmanek S, Pena S; et al. Annual number of adults hospitalized with pneumococcal pneumonia in the United States. ISPPD 2020, Abstract #473.
   Google Scholar
• Vila-Corcoles A, Ochoa-Gondar O, Vila-Rovira A, et al. Incidence and risk of pneumococcal pneumonia in adults with distinct underlying medical conditions: a population-based study. Lung. 2020 Jun;198(3):481–489. PubMed PMID: 32253492.
   PubMed Web of Science ®Google Scholar
• Bewick T, Sheppard C, Greenwood S, et al. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax. 2012 Jun;67(6):540–545. PubMed PMID: 22374921.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, streptococcus pneumoniae, 2018 [ cited 2020 Aug 10]. Available from: https://www.cdc.gov/abcs/reports-findings/survreports/spneu18.html.
   Google Scholar
• Meder KN, Jayasinghe S, Beard F, et al. Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalizations in indigenous and non-indigenous australians. Clin Infect Dis. 2020 Jun 10;70(12):2607–2615. PubMed PMID: 31388670.
   PubMed Web of Science ®Google Scholar
• Albrich WC, Rassouli F, Waldeck F, et al. Influence of older age and other risk factors on pneumonia hospitalization in Switzerland in the pneumococcal vaccine era. Front Med (Lausanne). 2019;6:286. PubMed PMID: 31867337; PubMed Central PMCID: PMC6906144.
   PubMed Web of Science ®Google Scholar
• LeBlanc J, ElSherif M, Ye L, et al. Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015. BMJ Open Respir Res. 2020 Mar;7(1). PubMed PMID: 32188585; PubMed Central PMCID: PMC7078693.
   PubMed Web of Science ®Google Scholar
• Corrales-Medina VF, Musher DM, Shachkina S, et al. Acute pneumonia and the cardiovascular system. Lancet. 2013 Feb 9;381(9865):496–505. PubMed PMID: 23332146.
   PubMed Web of Science ®Google Scholar
• O’Meara ES, White M, Siscovick DS, et al. Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival. J Am Geriatr Soc. 2005 Jul;53(7):1108–1116. PubMed PMID: 16108926.
   PubMed Web of Science ®Google Scholar
• Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis. 2008 Jul 15;47(2):182–187. PubMed PMID: 18533841.
   PubMed Web of Science ®Google Scholar
• Bornheimer R, Shea KM, Sato R, et al. Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease. PLoS One. 2017;12(10):e0184877. PubMed PMID: 29028810; PubMed Central PMCID: PMC5640217.
   PubMed Web of Science ®Google Scholar
• Johnstone J, Eurich DT, Majumdar SR, et al. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine (Baltimore). 2008 Nov;87(6):329–334. PubMed PMID: 19011504.
   PubMed Web of Science ®Google Scholar
• Yende S, Angus DC, Ali IS, et al. Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc. 2007 Apr;55(4):518–525. PubMed PMID: 17397429.
   PubMed Web of Science ®Google Scholar
• Restrepo MI, Faverio P, Anzueto A. Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis. 2013 Apr;26(2):151–158. PubMed PMID: 23426328; PubMed Central PMCID: PMC4066634.
   PubMed Web of Science ®Google Scholar
• Kolditz M, Braeken D, Ewig S, et al. Severity Assessment and the Immediate and Long-Term Prognosis in Community-Acquired Pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):886–896. PubMed PMID: 27960212.
   PubMed Web of Science ®Google Scholar
• Krone CL, Van De Groep K, Trzcinski K, et al. Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions. Lancet Respir Med. 2014 Feb;2(2):141–153. PubMed PMID: 24503269.
   PubMed Web of Science ®Google Scholar
• Uyar B, Palmer D, Kowald A, et al. Single-cell analyses of aging, inflammation and senescence. Ageing Res Rev. 2020 Sep;16(64):101156. PubMed PMID: 32949770; PubMed Central PMCID: PMC7493798.
   PubMed Web of Science ®Google Scholar
• Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007 Jan;128(1):92–105. PubMed ID PMID: 17116321.
   PubMed Web of Science ®Google Scholar
• Shivshankar P, Boyd AR, Le Saux CJ, et al. Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. Aging Cell. 2011 Oct;10(5):798–806. PubMed PMID: 21615674; PubMed Central PMCID: PMC3173515.
   PubMed Web of Science ®Google Scholar
• Okazaki T, Ebihara S, Mori T, et al. Association between sarcopenia and pneumonia in older people. Geriatr Gerontol Int. 2020 Jan;20(1):7–13. PubMed PMID: 31808265.
   PubMed Web of Science ®Google Scholar
• Hinojosa E, Boyd AR, Orihuela CJ. Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia. J Infect Dis. 2009 Aug 15;200(4):546–554. PubMed PMID: 19586419; PubMed Central PMCID: PMC3102250.
   PubMed Web of Science ®Google Scholar
• Van Der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009 Oct 31;374(9700):1543–1556. PubMed PMID: 19880020.
   PubMed Web of Science ®Google Scholar
• Krone CL, Trzciński K, Zborowski T, et al. Impaired innate mucosal immunity in aged mice permits prolonged Streptococcus pneumoniae colonization. Infect Immun. 2013 Dec;81(12):4615–4625. PubMed PMID: 24082075; PubMed Central PMCID: PMC3837976.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Rooney K, Choi AMK, et al. NLRP3 inflammasome activation in aged macrophages is diminished during Streptococcus pneumoniae infection. Am J Physiol Lung Cell Mol Physiol. 2018;314(3):L372–L387. PubMed PMID: 29097427.
   PubMed Web of Science ®Google Scholar
• Yende S, Tuomanen EI, Wunderink R, et al. Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. Am J Respir Crit Care Med. 2005 Dec 1;172(11):1440–6. PubMed PMID: 16166617; PubMec Central PMCID: PMC2718438.
   PubMed Web of Science ®Google Scholar
• Hinojosa CA, Suresh A, Babu R, et al. Elevated A20 contributes to age-dependent macrophage dysfunction in the lungs. Exp Gerontol. 2014 Jun;54:58–66. PubMed PMID: 24440463; PubMed Central PMCID: PMC3989429.
   PubMed Web of Science ®Google Scholar
• Boyd AR, Shivshankar P, Jiang S, et al. Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia. Exp Gerontol. 2012 Jul;47(7):507–518. PubMed PMID: 22548913; PubMed Central PMCID: PMC3368096.
   PubMed Web of Science ®Google Scholar
• Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004 May;395:687–699. PubMed ID PMID: 15130663.
   PubMed Web of Science ®Google Scholar
• Spencer NF, Poynter ME, Im SY, et al. Constitutive activation of NF-kappa B in an animal model of aging. Int Immunol. 1997 Oct;9(10):1581–1588. PubMed PMID: 9352364.
   PubMed Web of Science ®Google Scholar
• Kreiling JA, Tamamori-Adachi M, Sexton AN, et al. Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell. 2011;10(2):292–304. PubMed PMID: 21176091.
   PubMed Web of Science ®Google Scholar
• Van Duin D, Mohanty S, Thomas V, et al. Age-associated defect in human TLR-1/2 function. J Immunol. 2007 Jan 15;178(2):970–975. PubMed PMID: 17202359.
   PubMed Web of Science ®Google Scholar
• Nyugen J, Agrawal S, Gollapudi S, et al. Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol. 2010 Nov;30(6):806–813. PubMed PMID: 20703784; PubMed Central PMCID: PMC2970801.
   PubMed Web of Science ®Google Scholar
• Grubb BR, Livraghi-Butrico A, Rogers TD, et al. Reduced mucociliary clearance in old mice is associated with a decrease in Muc5b mucin. Am J Physiol Lung Cell Mol Physiol. 2016 May 1;310(9):L860–7. PubMed PMID: 26968767; PubMed Central PMCID: PMC4867354.
   PubMed Web of Science ®Google Scholar
• Svartengren M, Falk R, Philipson K. Long-term clearance from small airways decreases with age. J European Respiratory Journal. Eur Respir J. 2005;26(4):609–615. PubMed PMID: 16204590.
   Google Scholar
• Proença De Oliveira-maul J, Barbosa De Carvalho H, Dm G, et al. Aging, diabetes, and hypertension are associated with decreased nasal mucociliary clearance. Chest. 2013 Apr;143(4):1091–1097. PubMed PMID: 23100111.
   PubMed Web of Science ®Google Scholar
• Renshaw M, Rockwell J, Engleman C, et al. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol. 2002 Nov 1;169(9):4697–4701. PubMed PMID: 12391175.
   PubMed Web of Science ®Google Scholar
• Bhalla M, Simmons SR, Abamonte A, et al. Extracellular adenosine signaling reverses the age-driven decline in the ability of neutrophils to kill Streptococcus pneumoniae. Aging Cell. 2020;19(10):e13218. 2020/08/13;n/a(n/a).
   PubMed Web of Science ®Google Scholar
• Simell B, Vuorela A, Ekström N, et al. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. Vaccine. 2011 Feb 24;29(10):1929–1934. PubMed PMID: 21236231.
   PubMed Web of Science ®Google Scholar
• Meyer KC, Rosenthal NS, Soergel P, et al. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev. 1998 Aug 14;104(2):169–181. PubMed PMID: 9792195.
   PubMed Web of Science ®Google Scholar
• Mahbub S, Deburghgraeve CR, Kovacs EJ. Advanced age impairs macrophage polarization. J Interferon Cytokine Res. 2012;32(1):18–26. PubMed PMID: 22175541.
   PubMed Web of Science ®Google Scholar
• Gupta S. Role of dendritic cells in innate and adaptive immune response in human aging. Exp Gerontol. 2014 Jun;54:47–52. PubMed PMID: 24370374.
   PubMed Web of Science ®Google Scholar
• Orsini G, Legitimo A, Failli A, et al. Enumeration of human peripheral blood dendritic cells throughout the life. Int Immunol. 2012 Jun;24(6):347–356. PubMed PMID: 22345276.
   PubMed Web of Science ®Google Scholar
• Meyer KC, Ershler W, Rosenthal NS, et al. Immune dysregulation in the aging human lung. Am J Respir Crit Care Med. 1996 Mar;153(3):1072–9. PubMed ID PMID: 8630547.
   PubMed Web of Science ®Google Scholar
• Van Der Geest KS, Abdulahad WH, Tete SM, et al. Aging disturbs the balance between effector and regulatory CD4+ T cells. Exp Gerontol. 2014 Dec;60:190–196. PubMed PMID: 25449852.
   PubMed Web of Science ®Google Scholar
• Adler H, German EL, Mitsi E, et al. Experimental human pneumococcal colonisation in older adults is feasible and safe, not immunogenic. Am J Respir Crit Care Med. 2021 Mar 1;203(5):604-613. PubMed PMID: 32941735; PubMed Central PMCID: PMC7924584.
   Web of Science ®Google Scholar
• Shi Y, Yamazaki T, Okubo Y, et al. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol. 2005 Sep 1;175(5):3262–3267. PubMed PMID: 16116217.
   PubMed Web of Science ®Google Scholar
• Simell B, Lahdenkari M, Reunanen A, et al. Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clin Vaccine Immunol. 2008 Sep;15(9):1391–1397. PubMed PMID: 18596205; PubMed Central PMCID: PMC2546667.
   PubMed Web of Science ®Google Scholar
• Romero-Steiner S, Musher DM, Cetron MS, et al. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis. 1999 Aug;29(2):281–288. PubMed PMID: 10476727.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Zhurbenko N, Quach TD, Hopkins TJ, et al. Human B-1 cells and B-1 cell antibodies change with advancing age. Front Immunol. 2019;10:483. PubMed PMID: 30941130; PubMed Central PMCID: PMC6433875.
   PubMed Web of Science ®Google Scholar
• Park S, Nahm MH. Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations. Infect Immun. 2011;79(1):314–320. PubMed PMID: 21041499.
   PubMed Web of Science ®Google Scholar
• Kolibab K, Smithson SL, Shriner AK, et al. Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity. Immun Ageing. 2005;2(1):10. PubMed PMID: 15982420.
   PubMedGoogle Scholar
• Infante AJMJ, Orihuela CJ. Mechanisms of predisposition to pneumonia: infants, the elderly and viral infections. In: Brown JHS, Orihuela CJ, editors. Streptococcus pneumoniae. Amsterdam: Academic Press; 2015. p. 363–382.
   Google Scholar
• Kikawada M, Iwamoto T, Takasaki M. Aspiration and infection in the elderly: epidemiology, diagnosis and management. Drugs Aging. 2005;22(2):115–130. PubMed PMID: 15733019.
   PubMed Web of Science ®Google Scholar
• Arguedas A, Trzciński K, O’Brien KL, et al. Upper respiratory tract colonization with Streptococcus pneumoniae in adults. Expert Rev Vaccines. 2020 Apr;19(4):353–366. PubMed PMID: 32237926.
   PubMed Web of Science ®Google Scholar
• Miellet WR, Van Veldhuizen J, Nicolaie MA, et al. Influenza-like Illness exacerbates pneumococcal carriage in older adults. Clin Infect Dis. 2020 Oct 30. ciaa1551. PubMed PMID: 33124669.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest. 2009 Jul;119(7):1899–1909. PubMed PMID: 19509469; PubMed Central PMCID: PMC2701860.
   PubMed Web of Science ®Google Scholar
• Goncalves MT, Mitchell TJ, Lord JM. Immune ageing and susceptibility to Streptococcus pneumoniae. Biogerontology. 2016 Jun;17(3):449–465. PubMed PMID: 26472172.
   PubMed Web of Science ®Google Scholar
• Boyd AR, Orihuela CJ. Dysregulated inflammation as a risk factor for pneumonia in the elderly. Aging Dis. 2011 Dec;2(6):487–500. PubMed PMID: 22288022; PubMed Central PMCID: PMC3265328.
   PubMed Web of Science ®Google Scholar
• Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transplant international: official journal of the European Society for Organ Transplantation. Transpl Int. 2009 Nov;2211:1041–1050. PMID: 19624493.
   Google Scholar
• Goronzy JJ, Weyand CM. Mechanisms underlying T cell ageing. Nat Rev Immunol. 2019 Sep;19(9):573–583. PubMed PMID: 31186548.
   PubMed Web of Science ®Google Scholar
• Naylor K, Li G, Vallejo AN, et al. The influence of age on T cell generation and TCR diversity. J Immunol. 2005 Jun 1;174(11):7446–7452. PubMed PMID: 15905594.
   PubMed Web of Science ®Google Scholar
• Effros RB, Cai Z, Linton PJ. CD8 T cells and aging. Crit Rev Immunol. 2003;23(1–2):45–64. PubMed PMID: 12906259.
   PubMed Web of Science ®Google Scholar
• Goronzy JJ, Lee WW, Weyand CM. Aging and T-cell diversity. Exp Gerontol. 2007 May;42(5):400–406. PubMed PMID: 17218073; PubMed Central PMCID: PMC2680153.
   PubMed Web of Science ®Google Scholar
• Malley R, Srivastava A, Lipsitch M, et al. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun. 2006 Apr;74(4):2187–2195. PubMed PMID: 16552049; PubMed Central PMCID: PMC1418935.
   PubMed Web of Science ®Google Scholar
• Ramos-Sevillano E, Ercoli G, Brown JS. Mechanisms of Naturally Acquired Immunity to Streptococcus pneumoniae. Front Immunol. 2019;10:358. PubMed PMID: 30881363; PubMed Central PMCID: PMC6405633.
   PubMed Web of Science ®Google Scholar
• Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008 Sep 19;4(9):e1000159. PubMed PMID: 18802458; PubMed Central PMCID: PMC2528945.
   PubMed Web of Science ®Google Scholar
• Malley R, Trzcinski K, Srivastava A, et al. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4848–4853. PubMed PMID: 15781870; PubMed Central PMCID: PMC555733.
   PubMed Web of Science ®Google Scholar
• Trzcinski K, Thompson C, Malley R, et al. Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect Immun. 2005 Oct;73(10):7043–7046. PubMed PMID: 16177389; PubMed Central PMCID: PMC1230924.
   PubMed Web of Science ®Google Scholar
• Shinefield HR, Black S. Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J. 2000 Apr;19(4):394–397. PubMed PMID: 10783042.
   PubMed Web of Science ®Google Scholar
• Appay V, Rowland-Jones SL. Premature ageing of the immune system: the cause of AIDS? Trends Immunol. 2002 Dec;23(12):580–585. PubMed PMID: 12464569.
   PubMed Web of Science ®Google Scholar
• Wilson R, Cohen JM, Reglinski M, et al. Naturally acquired human immunity to pneumococcus is dependent on antibody to protein antigens. PLoS Pathog. 2017 Jan;13(1):e1006137. PubMed PMID: 28135322; PubMed Central PMCID: PMC5279798.
   PubMed Web of Science ®Google Scholar
• Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med. 2003 Apr 7;197(7):939–945. PubMed PMID: 12682112; PubMed Central PMCID: PMC2193885.
   PubMed Web of Science ®Google Scholar
• Papadatou I, Tzovara I, Licciardi PV. The role of serotype-specific immunological memory in pneumococcal vaccination: current knowledge and future prospects. Vaccines (Basel). 2019 Jan 29;7(1). PubMed PMID: 30700048; PubMed Central PMCID: PMC6466264.
   Web of Science ®Google Scholar
• Jha V, Janoff EN. Complementary Role of CD4+ T cells in response to pneumococcal polysaccharide vaccines in humans. Vaccines (Basel). 2019 Feb 11;7(1). PubMed PMID: 30754689; PubMed Central PMCID: PMC6466080.
   PubMed Web of Science ®Google Scholar
• Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines. 2011 Mar;10(3):307–322. PubMed PMID: 21434799.
   PubMed Web of Science ®Google Scholar
• Farmaki PF, Chini MC, Mangafas NM, et al. Immunogenicity and immunological memory induced by the 13-valent pneumococcal conjugate followed by the 23-valent polysaccharide vaccine in hiv-infected adults. J Infect Dis. 2018 Jun 5;218(1):26–34. PubMed PMID: 29722823.
   PubMed Web of Science ®Google Scholar
• Pollard AJ, Perrett KP, Beverley PC. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol. 2009 Mar 9;9(3):213–220. PubMed PMID: 19214194.
   PubMed Web of Science ®Google Scholar
• Wu YC, Kipling D, Dunn-Walters DK. Age-related changes in human peripheral blood igh repertoire following vaccination. Front Immunol. 2012;3:193. PubMed PMID: 22787463; PubMed Central PMCID: PMC3391689.
   PubMed Web of Science ®Google Scholar
• Su I, Tarakhovsky A. B-1 cells: orthodox or conformist? Curr Opin Immunol. 2000 Apr;12(2):191–194. PubMed PMID: 10712945.
   PubMed Web of Science ®Google Scholar
• Weksler ME. Changes in the B-cell repertoire with age. Vaccine. 2000 Feb 25;18(16):1624–1628. PubMed PMID: 10689139.
   PubMed Web of Science ®Google Scholar
• Weksler ME, Goodhardt M, Szabo P. The effect of age on B cell development and humoral immunity. Springer Semin Immunopathol. 2002;24(1):35–52. PubMed PMID: 11974580.
   PubMed Web of Science ®Google Scholar
• Pace D. Glycoconjugate vaccines. Expert Opin Biol Ther. 2013 Jan;13(1):11–33. PubMed PMID: 22992106.
   PubMed Web of Science ®Google Scholar
• Hutter J, Lepenies B. Carbohydrate-based vaccines: an overview. Methods Mol Biol. 2015;1331:1–10. PubMed PMID: 26169731.
   PubMedGoogle Scholar
• Marra F, Vadlamudi NK. Efficacy and safety of the pneumococcal conjugate-13 valent vaccine in adults. Aging Dis. 2019 Apr;10(2):404–418. PubMed PMID: 31011485; PubMed Central PMCID: PMC6457056.
   PubMed Web of Science ®Google Scholar
• Vadlamudi NK, Parhar K, Altre Malana KL, et al. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: a systematic review and meta-analysis. Vaccine. 2019 Feb 14;37(8):1021–1029. PubMed PMID: 30685252.
   PubMed Web of Science ®Google Scholar
• Puchta A, Naidoo A, Verschoor CP, et al. TNF drives monocyte dysfunction with age and results in impaired anti-pneumococcal immunity. PLoS Pathog. 2016 Jan;12(1):e1005368. PubMed PMID: 26766566; PubMed Central PMCID: PMC4713203.
   PubMed Web of Science ®Google Scholar
• World Health Organization. World report on ageing and health 2015 [ cited 2020 Aug 10]. Available from: https://www.who.int/ageing/publications/world-report-2015/en/.
   Google Scholar
• World Health Organization. Decade of Health Ageing 2020-2030. 2020 [ cited 2020 October 10]. Available from: https://www.who.int/initiatives/decade-of-healthy-ageing.
   Google Scholar
• World Health Organization. Global Vaccine Action Plan 2011-2020 2020 [ cited 2020 October 10]. Available from: https://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/.
   Google Scholar
• World Health Organization. Immunization Agenda 2030: a global strategy to leave no one behind. 2020 [ cited 2020 October 10]. Available from: https://www.who.int/immunization/immunization_agenda_2030/en/
   Google Scholar
• Rudnicka E, Napierala P, Podfigurna A, et al. The World Health Organization (WHO) approach to healthy ageing. Maturitas. 2020 Sep;139:6–11. PubMed PMID: 32747042; PubMed Central PMCID: PMC7250103.
   PubMed Web of Science ®Google Scholar
• International Federation on Ageing. Adult Immunization Advocacy Summit Report 2015 [ cited 2020 Aug 30]. Available from: https://ifa.ngo/wp-content/uploads/2015/08/IFA-Adult-Immunization-Advocacy-Summit-Report.pdf.
   Google Scholar
• Doherty TM, Del Giudice G, Maggi S. Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion. Ann Med. 2019 Mar;51(2):128–140. PubMed PMID: 31025882.
   PubMed Web of Science ®Google Scholar
• Jorgensen P, Mereckiene J, Cotter S, et al. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine. 2018 Jan 25;36(4):442–452. PubMed PMID: 29287683; PubMed Central PMCID: PMC5777640.
   PubMed Web of Science ®Google Scholar
• Matanock A, Lee G, Gierke R, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1069–1075. PubMed PMID: 31751323; PubMed Central PMCID: PMC6871896.
   PubMed Web of Science ®Google Scholar
• Healthy People 2020. Immunization and infectious diseases: objectives [ cited 2020 August 15]. Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives.
   Google Scholar
• Privor-Dumm LA, Ga P, Barratt J, et al. A global agenda for older adult immunization in the COVID-19 era: a roadmap for action. Vaccine. 2020 Jul 3:S0264-410X(20)30885-9. PubMed PMID: 32703743; PubMed Central PMCID: PMC7332930.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Altered Immunocompetence [ cited 2020 October 10]. Available from: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html.
   Google Scholar
• Rubin LG, Levin MJ, Ljungman P, et al. IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2013 Feb;58(3):e44–100. PubMed PMID: 24311479.
   PubMed Web of Science ®Google Scholar